Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Shelton
Rhidian
R
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004554:Electric Countershock / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans
D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents